29 results
F-1
EX-10.12.4
AMYT
Amryt Pharma Plc
23 Jun 20
Registration statement (foreign)
5:21pm
as of the date set forth above.
AEGERION PHARMACEUTICALS, INC.
ACCREDO HEALTH GROUP, INC.
By:
/s/ Christine Strobele
By:
/s/ Bill Martin
Name:
Christine Strobele
Name:
Bill Martin
Title:
VP Pt Engagement
Title:
VP
Date:
DRS/A
EX-10.12
AMYT
Amryt Pharma Plc
11 May 20
Draft registration statement (amended)
12:00am
as of the date set forth above.
AEGERION PHARMACEUTICALS, INC.
ACCREDO HEALTH GROUP, INC.
By:
/s/ Christine Strobele
By:
/s/ Bill Martin
Name:
Christine Strobele
Name:
Bill Martin
Title:
VP Pt Engagement
Title:
VP
Date:
6-K
EX-99.1
AMYT
Amryt Pharma Plc
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
with their instructions, at the AGM.
AGM - Listen-Live Facility: To support engagement with our Shareholders, a listen-live telephone facility
6-K
EX-99.1
AMYT
Amryt Pharma Plc
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
territories. We are also pleased to extend our engagement with Medison and further benefit from their expertise in Canada and other territories.”
About
6-K
EX-99.3
AMYT
Amryt Pharma Plc
31 Mar 21
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
7:00am
, developing and commercializing novel treatments for rare diseases, today provides an update on its engagement with the FDA on Myalept® and its
6-K
EX-99.1
uzcocdo
3 Nov 20
Current report (foreign)
8:45am
6-K
EX-99.1
47cahg4lgpaz
28 Jun 21
Current report (foreign)
9:16am
6-K
EX-10.1
6zkb0ax3oc6d
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
6eijkru5ylnmc
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am
F-1
EX-10.13
li5rjz
23 Jun 20
Registration statement (foreign)
5:21pm
424B3
m7un28bdzkl7pf71h
28 Jun 21
Prospectus supplement
9:18am
424B3
te1tgm16 zkplnhe20
28 Jun 21
Prospectus supplement
9:17am
DRS/A
EX-10.13
xdo 18ya78
11 May 20
Draft registration statement (amended)
12:00am
F-1/A
EX-10.13
q1vqk4lf4 jndi54cn0j
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
DRS/A
EX-10.12
o43tin6 lm4dmmw
11 May 20
Draft registration statement (amended)
12:00am
F-1
EX-10.12.5
xyuew
23 Jun 20
Registration statement (foreign)
5:21pm
F-4/A
2wx12
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
424B3
xrpw7lb
1 Jul 21
Prospectus supplement
5:20pm
F-4
09bbwwgn 50hy5tycvo2
15 Jun 21
Registration of securities (foreign)
12:00am
6-K
EX-99.2
lzd1bhcmgt4susg331dv
13 Sep 21
Current report (foreign)
8:48am